Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1079
mi
from
Hyattsville, MD
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1079
mi
from
Hyattsville, MD
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1223
mi
from
Midland, MI
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1223
mi
from
Midland, MI
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1217
mi
from
Petoskey, MI
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1217
mi
from
Petoskey, MI
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1252
mi
from
Kalispell, MT
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1252
mi
from
Kalispell, MT
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1052
mi
from
Omaha, NE
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1052
mi
from
Omaha, NE
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1080
mi
from
Las Vegas, NV
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1080
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1219
mi
from
Somerset, NJ
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1219
mi
from
Somerset, NJ
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1044
mi
from
Albuquerque, NM
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1044
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1220
mi
from
Saratoga Springs, NY
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1220
mi
from
Saratoga Springs, NY
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1049
mi
from
West Seneca, NY
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1049
mi
from
West Seneca, NY
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1085
mi
from
Chapel Hill, NC
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1085
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1074
mi
from
Charlotte, NC
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1074
mi
from
Charlotte, NC
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1056
mi
from
Morehead City, NC
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1056
mi
from
Morehead City, NC
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 123
mi
from
Winston-Salem, NC
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 123
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1075
mi
from
Fargo, ND
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1075
mi
from
Fargo, ND
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1055
mi
from
Oklahoma City, OK
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1055
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1042
mi
from
Cumberland, RI
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1042
mi
from
Cumberland, RI
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1048
mi
from
Kingwood, TX
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1048
mi
from
Kingwood, TX
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1070
mi
from
Lampasas, TX
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1070
mi
from
Lampasas, TX
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1222
mi
from
Lewisville, TX
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1222
mi
from
Lewisville, TX
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1081
mi
from
North Richland Hills, TX
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1081
mi
from
North Richland Hills, TX
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 009
mi
from
San Antonio, TX
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 009
mi
from
San Antonio, TX
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research
mi
from
Salt Lake City, UT
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1258
mi
from
Champaign, IL
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1258
mi
from
Champaign, IL
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1224
mi
from
Covington, KY
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1224
mi
from
Covington, KY
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1228
mi
from
Annapolis, MD
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1228
mi
from
Annapolis, MD
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1254
mi
from
Ypsilanti, MI
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1254
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1264
mi
from
Bronx, NY
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1264
mi
from
Bronx, NY
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
INC Research
mi
from
Wilmington, NC
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
INC Research
mi
from
Wilmington, NC
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1260
mi
from
Lancaster, PA
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1260
mi
from
Lancaster, PA
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1225
mi
from
Austin, TX
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1225
mi
from
Austin, TX
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 015
mi
from
Dallas, TX
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 015
mi
from
Dallas, TX
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1230
mi
from
Salem, VA
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1230
mi
from
Salem, VA
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 5013
mi
from
Vancouver,
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 5013
mi
from
Vancouver,
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1054
mi
from
Saint Louis, MO
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1054
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated:  12/31/1969
Research Site 1266
mi
from
Lindsay, OK
Bexagliflozin Efficacy and Safety Trial (BEST)
A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
Status: Enrolling
Updated: 12/31/1969
Research Site 1266
mi
from
Lindsay, OK
Click here to add this to my saved trials
Yoga for Type 2 Diabetes
Yoga as a Complementary Therapy for Type 2 Diabetes: An Initial Investigation
Status: Enrolling
Updated:  12/31/1969
Miriam Hospital
mi
from
Providence, RI
Yoga for Type 2 Diabetes
Yoga as a Complementary Therapy for Type 2 Diabetes: An Initial Investigation
Status: Enrolling
Updated: 12/31/1969
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Anniston, AL
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Anniston, AL
Click here to add this to my saved trials
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Birmingham, AL
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Tuscumbia, AL
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Tuscumbia, AL
Click here to add this to my saved trials
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Glendale, AZ
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Glendale, AZ
Click here to add this to my saved trials
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Little Rock, AR
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Carmichael, CA
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Carmichael, CA
Click here to add this to my saved trials
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Coronado, CA
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Coronado, CA
Click here to add this to my saved trials
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Encino, CA
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Encino, CA
Click here to add this to my saved trials
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Fresno, CA
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Fresno, CA
Click here to add this to my saved trials
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Los Alamitos, CA
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Los Alamitos, CA
Click here to add this to my saved trials
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Palm Springs, CA
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Palm Springs, CA
Click here to add this to my saved trials
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Poway, CA
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Poway, CA
Click here to add this to my saved trials
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Walnut Creek, CA
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Walnut Creek, CA
Click here to add this to my saved trials